Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
21.06
-1.16 (-5.22%)
Oct 10, 2024, 1:55 PM EDT - Market open
Cartesian Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Oct '24 Oct 10, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 503 | 107 | - | - |
| Enterprise Value | 459 | 123 | - | - |
| Last Close Price | 22.22 | 20.68 | - | - |
| PE Ratio | - | -0.42 | - | - |
| PS Ratio | 3.35 | 4.11 | - | - |
| PB Ratio | -4.74 | -0.77 | - | - |
| P/FCF Ratio | -7.38 | -2.08 | - | - |
| P/OCF Ratio | -7.65 | -2.09 | - | - |
| EV/Sales Ratio | 8.48 | 4.75 | - | - |
| EV/EBITDA Ratio | -10.97 | -1.68 | - | - |
| EV/EBIT Ratio | -10.71 | -1.66 | - | - |
| EV/FCF Ratio | -5.95 | -2.40 | - | - |
| Debt / Equity Ratio | -0.15 | -0.08 | 0.40 | 0.18 |
| Debt / EBITDA Ratio | - | - | 2.01 | - |
| Debt / FCF Ratio | -0.23 | -0.21 | -1.16 | -0.02 |
| Asset Turnover | - | 0.11 | 1.26 | - |
| Quick Ratio | 4.70 | 1.26 | 5.76 | 6.38 |
| Current Ratio | 4.78 | 1.33 | 5.91 | 6.42 |
| Return on Equity (ROE) | - | - | 70.21% | - |
| Return on Assets (ROA) | - | -19.75% | 10.35% | - |
| Return on Capital (ROIC) | - | -3022.09% | 12.98% | - |
| Earnings Yield | -50.33% | -205.34% | - | - |
| FCF Yield | -12.27% | -48.01% | - | - |
| Buyback Yield / Dilution | -67.57% | -6.33% | -27.59% | - |
| Total Shareholder Return | -67.57% | -6.33% | -27.59% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.